The Cooper Companies, Inc. (NYSE:COO) will unveil its latest earnings on Thursday, June 2, 2011. Cooper Companies, Inc. develops, manufactures and markets healthcare products, primarily medical devices through its two business units, CooperVision, Inc. and CooperSurgical, Inc.
The Cooper Companies, Inc. Earnings Preview Cheat Sheet
Wall St. Earnings Expectations: The average analyst is estimating profit of 93 cents per share, a rise of 52.5% from the same quarter a year ago. Estimates range from net income of 89 cents per share to profit of $1.03 per share. Over the past three months, the consensus estimate has moved up from 83 cents. The consensus estimate is unchanged from a month ago. For the year, analysts are projecting net income of $3.92 per share, a rise of 28.9% from last year.
Past Earnings Performance: The company is looking to top estimates for the third-straight quarter. Last quarter, it reported profit of 85 cents per share against a mean estimate of net income of 86 cents, and the quarter before, the company exceeded forecasts by 18 cents with profit of $1.04 versus a mean estimate of net income of 86 cents.
Wall St. Revenue Expectations: On average, analysts predict $314.7 million in revenue this quarter, a rise of 8.8% from the year ago quarter. Analysts are forecasting total revenue of $1.28 billion for the year, from last year’s revenue of $1.16 billion.
Analyst Ratings: Of the analysts surveyed, there were no sell ratings, with five buys.
The company has now seen net income rise in three-straight quarters. In the first quarter of the last fiscal year, net income rose 60% and in the fourth quarter of the last fiscal year, the figure rose 81.3%.
Revenue has risen the past four quarters. Revenue increased 10.5% to $293.2 million in first quarter of the last fiscal year. The figure rose 3.6% in fourth quarter of the last fiscal year from the year earlier and climbed 11% in third quarter of the last fiscal year from the year-ago quarter.
The company upped its gross margin by 2.7 percentage points in the last quarter. Revenue rose 12.7% while cost of sales rose 5.5% to $116.6 million from a year earlier.
Competitors to Watch: STAAR Surgical Company (NASDAQ:STAA), Teleflex Incorporated (NYSE:TFX), Utah Medical Products, Inc. (NASDAQ:UTMD), Atrion Corporation (NASDAQ:ATRI), Covidien plc (NYSE:COV), Shamir Optical Industry Ltd. (NASDAQ:SHMR), Novartis AG (NYSE:NVS), C.R. Bard, Inc. (NYSE:BCR), Johnson & Johnson (NYSE:JNJ), Intuitive Surgical (NASDAQ:ISRG), Medtronic (NYSE:MDT) and Boston Scientific Corp. (NYSE:BSX).
Recent Price Movement: Over the past three months, the stock price has risen $9.98 (16%) from $63.62 on March 3, 2011 to $73.60.
(Sources: YahooFinance and Xignite Financials)